Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Small Changes, System-Wide Impact

April 1, 2012

A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.

Ways to Recover Lost Margins

April 1, 2012

Recovery audits and other best practices in procurement can improve the bottom line.

Growing Your Biopharmaceutical Product Pipeline

April 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.

Preparing for an FDA Inspection in a Global Pharmaceutical Environment

April 1, 2012

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

A Strong Start to 2012

April 1, 2012

Better news about the global economy buoys life-sciences funding.

Knowledge Management Implementation

April 1, 2012

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

Manufacturers Wrestle with Drug Abuse and Critical Shortages

April 1, 2012

Soaring opioid use creates challenges for new drug development and supply-chain control.

Empire State Drug Development

March 2, 2012

An architectural wonder teaches the biopharmaceutical industry a valuable lesson in project management.

Considerations in Biopharmaceutical Outsourcing

March 2, 2012

Because of the complexity of the manufacturing processes for biologics, transfer of these processes to a contract manufacturer presents challenges.

ADVERTISEMENT

ADVERTISEMENT

Click here